Treatment of Advanced Ovarian Carcinoma in the Elderly

Abstract This study retrospectively analyzes the treatment of advanced ovarian cancer (Stages III and IV) in elderly patients (⩾65) compared to that in younger patients ( 2 , log rank, Kaplan-Meier, and Cox model analyses were performed for multiple variables including age, grade of tumor, adequacy of surgery, and dose intensity. The elderly significantly differed from the young in the following analyses: median length of hospitalization, 20 days vs 11 days ( P P = 0.02); initial chemotherapeutic dose reduction, 15.4% vs 0% ( P = 0.02); median survival compared to age, 19.2 months vs 36.7 months ( P